Amy Mullin has significant experience in clinical trial management and quality control within the biotechnology and pharmaceutical sectors. Currently serving as a Clinical Trial Manager for Rare Disease and Neuroscience at ICON plc since March 2015, Amy has also held the role of Laboratory Manager for Infectious Diseases at the same organization. Prior to this, Amy spent over a decade at Trinity Biotech, where roles included Quality Control Laboratory Manager, Quality Control Supervisor, and QC Biochemist. Earlier experience includes working as an Analytical Technician at Enfer Scientific from March 2001 to March 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices